APA (7th ed.) Citation

Xie, H., Tong, Q., Xiang, Z., Zhou, C., Wan, L., & Chen, J. (2022). Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway. Elsevier.

Chicago Style (17th ed.) Citation

Xie, Haifei, Qilin Tong, Zhinan Xiang, Chenggao Zhou, Luo-Sheng Wan, and Jiachun Chen. Demethylbellidifolin, a Potential Aldose Reductase Inhibitor Ameliorates Diabetic Nephropathy by Regulating the Polyol Pathway. Elsevier, 2022.

MLA (8th ed.) Citation

Xie, Haifei, et al. Demethylbellidifolin, a Potential Aldose Reductase Inhibitor Ameliorates Diabetic Nephropathy by Regulating the Polyol Pathway. Elsevier, 2022.